Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) saw unusually-high trading volume on Monday . Approximately 108,363 shares traded hands during trading, a decline of 23% from the previous session’s volume of 141,542 shares.The stock last traded at $17.26 and had previously closed at $18.06.
Wall Street Analyst Weigh In
CCAP has been the topic of several recent research reports. Raymond James upped their price target on Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a report on Friday, May 10th. Keefe, Bruyette & Woods upped their price target on Crescent Capital BDC from $18.50 to $19.00 and gave the stock an “outperform” rating in a report on Thursday, May 23rd. Finally, Wells Fargo & Company upped their price objective on Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Friday, July 26th.
Crescent Capital BDC Trading Down 2.8 %
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last released its quarterly earnings data on Wednesday, May 8th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.04. The business had revenue of $50.36 million during the quarter, compared to analysts’ expectations of $48.31 million. Crescent Capital BDC had a return on equity of 11.99% and a net margin of 53.32%. As a group, research analysts forecast that Crescent Capital BDC, Inc. will post 2.34 EPS for the current fiscal year.
Crescent Capital BDC Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, July 15th. Investors of record on Friday, June 28th were given a $0.42 dividend. The ex-dividend date was Friday, June 28th. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.41. This represents a $1.68 dividend on an annualized basis and a dividend yield of 9.57%. Crescent Capital BDC’s dividend payout ratio is 59.79%.
Hedge Funds Weigh In On Crescent Capital BDC
Hedge funds and other institutional investors have recently bought and sold shares of the company. International Assets Investment Management LLC purchased a new stake in shares of Crescent Capital BDC in the fourth quarter valued at $1,254,000. Confluence Investment Management LLC acquired a new position in shares of Crescent Capital BDC during the first quarter worth about $1,200,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new position in shares of Crescent Capital BDC during the fourth quarter worth about $843,000. Muzinich & Co. Inc. acquired a new position in shares of Crescent Capital BDC during the fourth quarter worth about $843,000. Finally, Mmbg Investment Advisors CO. acquired a new position in shares of Crescent Capital BDC during the fourth quarter worth about $612,000. 49.46% of the stock is owned by institutional investors and hedge funds.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- Insider Trading – What You Need to Know
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- Retail Stocks Investing, Explained
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Why Warren Buffett Just Sold Half His Stake in Apple Stock
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.